Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program

Stein MR, Soloway IJ, Jefferson KS, Roose RJ, Arnsten JH, Litwin AH. Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program. J Subst Abuse Treat. 2012;43(4):424-432.

Publication Type:

Journal Article

Authors:

Stein, M.R.; Soloway, I.J.; Jefferson, K.S.; Roose, R.J.; Arnsten, J.H.; Litwin, A.H.

Source:

J Subst Abuse Treat, Volume 43, Issue 4, p.424-432 (2012)

Keywords:

adherence, administration & dosage, Adult, adverse effects, Antiviral Agents, drug therapy, Drug Therapy,Combination, Drug Users, Female, genetics, Genotype, genotype 1, HCV, Hepacivirus, hepatitis, Hepatitis C, hepatitis C virus, Hepatitis C,Chronic, Heroin Dependence, Humans, Infection, Injections, interferon, Interferon-alpha, Internal Medicine, Male, Medication Adherence, Medicine, Methadone, methods, Middle Aged, New York, Opiate Substitution Treatment, Patients, peginterferon, Physical Examination, Polyethylene Glycols, Proteins, Psychotherapy,Group, Recombinant Proteins, rehabilitation, Research, Research Support, Retrospective Studies, Ribavirin, treatment, Treatment Outcome, Viral Load

Notes:

PMC3505858

Cited On:

HCV Testing and Linkage to Care

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/23036920

Export Citation:

RIS Format

Top